Roger Mack Hinson - Nov 10, 2021 Form 4 Insider Report for MEDNAX, INC. (MD)

Role
Pres., PDX & OBX Medical Group
Signature
/s/ Dominic J. Andreano, Attorney-in-Fact
Stock symbol
MD
Transactions as of
Nov 10, 2021
Transactions value $
-$249,744
Form type
4
Date filed
11/10/2021, 03:07 PM
Previous filing
Aug 11, 2021
Next filing
Mar 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MD Common Stock Sale -$250K -8.8K -7.57% $28.38 107K Nov 10, 2021 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sales made pursuant to reporting person's 10b5-1 trading plan adopted June 15, 2021.
F2 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $28.13 to $28.55 for a weighted average sales price of $28.38. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 Includes 62 shares acquired by reporting person through Issuer's Employee Stock Purchase Plan since the last Form 4 filing.